COLL COLLEGIUM PHARMACEUTICAL INC
2026Q1 · CUSIP 19459J104 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
264
Δ holders QoQ
-13
Breadth percentile
Top 89%
Whale holders
134
Δ whales
-4
Inst. holding value
$1.2B
New positions
41
Closed positions
54
Price momentum (1Q)
-27.0%
Put / Call
0/0
Breadth history (34 quarters)
Past Lit Events & Aftermath 11 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 16% | -27.0% | — |
| 2025Q3 | Top 17% | -0.4% | -24.5% |
| 2024Q3 | Top 16% | -0.3% | -1.4% |
| 2024Q1 | Top 7% | +11.1% | -8.9% |
| 2023Q1 | Top 9% | +2.5% | +9.3% |
| 2022Q3 | Top 11% | +29.5% | +10.9% |
| 2022Q1 | Top 17% | +14.6% | +37.0% |
| 2021Q1 | Top 15% | -10.8% | -14.5% |
Options Sentiment
Put holders
0
QoQ: 0
Call holders
0
QoQ: -1
See methodology →
Fundamentals
PE (TTM)
17.7
EPS (TTM)
$2.04
EPS YoY
+67.2%
Revenue (TTM)
$0.8B
Revenue YoY
+19.9%
Net margin
9.4%
ROE
24.0%
Debt ratio
81.1%
FCF (TTM)
$330M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.